ADMA — ADMA Biologics Inc · P/E 22, rev $238.9M

ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.

Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.

Use this ADMA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ADMA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ADMA SEC filings page. Lician reads the product cache first so this HTML stays unique to ADMA Biologics Inc even when a live quote feed is slow.

ADMA Biologics Inc latest statements (FY2025)

Latest cached year on this hub. Full ADMA income, balance, and cash tables.

  • Revenue$510.2M
  • Net Income$146.9M
  • Total Assets$624.2M
  • Total Debt$0
  • Free Cash Flow$27.8M

ADMA recent filings